← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Solidus Biosciences, Inc.
San Francisco, NY
$4,216,585
Total funding
8
Grants
Funding over time
peak $892.3K · FY2005–13$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$3,916,585 · 6
NSF$300,000 · 2
By mechanism
R42$2,667,353 · 2
R41$1,249,232 · 4
—$300,000 · 2
Investigators at Solidus Biosciences, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Integrated Biochip for In-Vitro Toxicology$603,616
R42 · FY2005 · ES
Integrated Biochip for In-Vitro Toxicology$542,254
R42 · FY2007 · ES
Integrated Biochip for In-Vitro Toxicology$535,599
R42 · FY2006 · ES
TeamChip for High-Throughput, Predictive Human Metabolism and Toxicology: Phase I$500,000
R42 · FY2012 · ES
TeamChip for High-Throughput, Predictive Human Metabolism and Toxicology: Phase I$485,884
R42 · FY2013 · ES
Integrated Biochip for In-Vitro Toxicology$400,615
R41 · FY2004 · ES
A High-Throughput Human Metabolic Stability Assay Chip for Early-Stage Drug Disco$200,607
R41 · FY2008 · GM
Heparin Glycan Microarray for Screening$200,000
R41 · FY2008 · RR
Heparin Glycan Microarray for Screening$200,000
R41 · FY2007 · RR
TeamChip for High-throughput, Predictive Human Metabolism and Toxicology$150,000
R41 · FY2010 · ES
STTR Phase I: Development of a Lead Optimization Chip for Drug Discovery$150,000
· FY2007 · TIP
STTR Phase I: High-Throughput RNAi Screening of Mammalian Cells$150,000
· FY2008 · TIP
Integrated Biochip for In-Vitro Toxicology$98,010
R41 · FY2003 · ES